Merck | MRK - Current Assets


Merck reported EUR13.77B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Adidas EUR 12.83B 546M Jun/2026
Adyen EUR 13.97B 2.28B Jun/2026
Akzo Nobel EUR 8.12B 594M Jun/2026
Alcon AG USD 6.62B 4M Jun/2026
Amadeus IT EUR 2.64B 324.6M Jun/2026
Amarin USD 602.76M 23.26M Jun/2026
AstraZeneca USD 27.97B 1.65B Jun/2026
BASF EUR 38.79B 1.18B Jun/2026
Bayer EUR 33.64B 1.66B Jun/2026
Beiersdorf EUR 6.66B 8M Dec/2025
Covestro EUR 5.91B 259M Dec/2025
Danone EUR 16.06B 2.83B Jun/2026
Fresenius EUR 11.61B 456M Jun/2026
Fresenius Medical Care EUR 7.69B 418.66M Jun/2026
Genmab DKK 2.8B 228M Jun/2026
Givaudan CHF 4.07B 258M Dec/2025
GlaxoSmithKline GBP 17.56B 202M Jun/2026
GRIFOLS EUR 5.31B 51M Jun/2026
Henkel EUR 11.93B 1.86B Jun/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Infineon EUR 10.29B 234M Jun/2026
Lakefront Biotherapeutics EUR 2.31B 751.38M Jun/2026
Linde USD 12.75B 574M Mar/2026
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 13.77B 393M Jun/2026
Novartis USD 27.35B 744M Jun/2026
Philips EUR 9.33B 454M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 31.52B 1.36B Jun/2026
UCB EUR 6.05B 733M Dec/2025